Evidence map›Paper›PMID 41813236›Full record

ArticleJournal of medical Internet research2026

Developing and Validating a Machine Learning Algorithm to Predict the Risk of Incident Opioid Use Disorder Among OneFlorida+ Patients: Prognostic Modeling Study.

Jabed Al Faysal, Weihsuan Lo-Ciganic, Walid F Gellad, Yonghui Wu, Christopher A Harle, Khoa Nguyen, James L Huang, Gerald Cochran, Debbie L Wilson, Stephanie As Staras and 8 more

Abstract readValidation Study
In one paragraph

Article in Journal of medical Internet research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jabed Al FaysalDepartment of Pharmaceutical Outcomes & Policy, University of Florida, 1889 Museum Road, Malachowsky Hall, Suite 6300, Gainesville, FL, 32611, United States, 12566946603.ORCID http://orcid.org/0009-0009-1093-0889
Weihsuan Lo-CiganicDivision of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.ORCID http://orcid.org/0000-0001-6590-4770
Walid F GelladDivision of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.ORCID http://orcid.org/0000-0002-6992-5197
Yonghui WuDepartment of Health Outcomes & Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States.ORCID http://orcid.org/0000-0002-6780-6135
Christopher A HarleDepartment of Health Policy and Management, School of Public Health, Indiana University, Indianapolis, IN, United States.ORCID http://orcid.org/0000-0002-4803-3632
Khoa NguyenDepartment of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, United States.ORCID http://orcid.org/0000-0002-0096-0293
James L HuangDepartment of Pharmaceutical Outcomes & Policy, University of Florida, 1889 Museum Road, Malachowsky Hall, Suite 6300, Gainesville, FL, 32611, United States, 12566946603.ORCID http://orcid.org/0000-0002-8286-4560
Gerald CochranDepartment of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, UT, United States.ORCID http://orcid.org/0000-0002-0153-0252
Debbie L WilsonDepartment of Pharmaceutical Outcomes & Policy, University of Florida, 1889 Museum Road, Malachowsky Hall, Suite 6300, Gainesville, FL, 32611, United States, 12566946603.ORCID http://orcid.org/0000-0002-1640-5497
Stephanie As StarasDepartment of Health Outcomes & Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States.ORCID http://orcid.org/0000-0002-0726-1524
Siegfried Of SchmidtDepartment of Community Health and Family Medicine, College of Medicine, University of Florida, Gainesville, FL, United States.ORCID http://orcid.org/0000-0001-5941-6009
Eric I RosenbergDepartment of Pharmaceutical Outcomes & Policy, University of Florida, 1889 Museum Road, Malachowsky Hall, Suite 6300, Gainesville, FL, 32611, United States, 12566946603.ORCID http://orcid.org/0000-0002-5396-0422
Danielle NelsonDepartment of Community Health and Family Medicine, College of Medicine, University of Florida, Gainesville, FL, United States.ORCID http://orcid.org/0000-0003-1261-239X
Shunhua YanDepartment of Pharmaceutical Outcomes & Policy, University of Florida, 1889 Museum Road, Malachowsky Hall, Suite 6300, Gainesville, FL, 32611, United States, 12566946603.ORCID http://orcid.org/0009-0006-6052-6428
Gary M ReisfieldDepartment of Pharmaceutical Outcomes & Policy, University of Florida, 1889 Museum Road, Malachowsky Hall, Suite 6300, Gainesville, FL, 32611, United States, 12566946603.ORCID http://orcid.org/0000-0002-5022-5430
William M GreeneDepartment of Psychiatry, College of Medicine, University of Florida, Gainesville, FL, United States.ORCID http://orcid.org/0000-0003-3433-7878
Courtney KuzaCenter for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, PA, United States.ORCID http://orcid.org/0000-0001-9137-0928
Md Mahmudul HasanDepartment of Pharmaceutical Outcomes & Policy, University of Florida, 1889 Museum Road, Malachowsky Hall, Suite 6300, Gainesville, FL, 32611, United States, 12566946603.ORCID http://orcid.org/0000-0001-5899-793X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Opioid use disorder (OUD) remains a critical public health crisis in the United States. Despite widespread policy and clinical interventions, early identification of individuals at risk for developing OUD remains challenging due to limitations in traditional screening approaches and a lack of individualized risk stratification methods. Machine learning (ML) methods offer an opportunity to develop timely, high-performing, and explainable predictive models that can enhance OUD prevention strategies in clinical settings. Objective: This study aims to develop and validate an ML model using electronic health record (EHR) data to predict the 3-month risk of incident OUD among adults initiating opioid therapy and to stratify patients into clinically actionable risk groups. Methods: This prognostic modeling study used 2017-2022 OneFlorida+ EHR data to develop and validate ML algorithms predicting 3-month incident OUD risk. We included 182,083 adults (≥18 y) without cancer, overdose, or OUD or hospice history who received ≥1 outpatient, noninjectable opioid prescription. Using 183 predictors measured in sequential 3-month intervals, we developed an elastic net, least absolute shrinkage and selection operator, gradient boosting machine (GBM), and random forest models on randomly split training, testing, and validation sets. Model performance was assessed using C-statistics, predictive values, and number needed to evaluate, with patients stratified into risk deciles for clinical applicability. Model explainability was assessed using Shapley additive explanations, and fairness was evaluated using standard metrics. We externally validated the best-performing model using an independent cohort from the 2018-2020 UPMC (formerly University of Pittsburgh Medical Center) health system. Results: In the validation sample (n=60,694), GBM (C-statistics=0.879, 95% CI 0.874-0.884) and elastic net (C-statistics=0.872, 95% CI 0.867-0.877) outperformed least absolute shrinkage and selection operator (C-statistics=0.846, 95% CI 0.840-0.851) and random forest (C-statistics=0.798, 95% CI 0.792-0.804), with GBM model requiring the fewest predictors (n=75) for predicting 3-month incident OUD. Using the GBM algorithm to predict the subsequent 3-month OUD risk, the top decile subgroup had a positive predictive value of 3.26%, a negative predictive value of 99.8%, and a number needed to evaluate of 31. The top decile (n=6696) captured ~68% of patients with OUD. Shapley additive explanations analysis identified age, number of outpatient visits, history of back and other pain conditions, comorbidity burden, and opioid prescribing patterns as the strongest predictors of incident OUD. Fairness assessment showed an acceptable false negative rate parity across race, age, and sex. In external validation on the UPMC cohort, the GBM model maintained good discrimination (C-statistics=0.756, 95% CI 0.750-0.762) and effective risk stratification. Conclusions: An ML algorithm predicting incident OUD derived from OneFlorida+ EHR data performed well in external validation with data using UPMC. The algorithm might be valuable for incident OUD risk prediction and stratification across health systems, with potential to inform early intervention.

Indexed as

AlgorithmsMachine LearningOpioid-Related DisordersAdultElectronic Health RecordsFemaleHumansMiddle AgedPrediction AlgorithmsPredictive Learning ModelsPrognosisexternal validationmachine learningOneFlorida+opioid use disorderrisk stratification

Identifiers

PMID41813236
PMCPMC12978897

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.